维普中文期刊产品整合服务
12篇 您的检索式:作者名="Negrier M"
    题名 作者 年代 出处 被引量
1Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial显示文摘Brian I Rini Bernard Escudier Piotr Tomczak Andrey Kaprin Cezary Szczylik Thomas E Hutson M Dror Michaelson Vera A Gorbunova Martin E Gore Igor G Rusakov Sylvie Negrier Yen-Chuan Ou Daniel Castellano Ho Yeong Lim Hirotsugu Uemura Jamal Tarazi David Cella 2011The Lancet . 2011 (9807)2011,,9807:2
2Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial显示文摘Brian I Rini Bernard Escudier Piotr Tomczak Andrey Kaprin Cezary Szczylik Thomas E Hutson M Dror Michaelson Vera A Gorbunova Martin E Gore Igor G Rusakov Sylvie Negrier Yen-Chuan Ou Daniel Castellano Ho Yeong Lim Hirotsugu Uemura Jamal Tarazi David Cella 2011The Lancet2011,,9807:2
3Sequential sorafenib and sunitinib for renal cell carcinoma显示文摘Sablin M P Negrier S Ravaud A 2009J Urol2009,182,1:1
4Serum level of interleukin-6 as a prognosis factor in metastatic r e nal cellcarcinoma显示文摘Blay JY Negrier M Comb aret V etal 1992Cancer Res1992,52,:1
5Serum Levels of interleukin-6 as a prognosis factor in matastatic renal cell carcimoma显示文摘BLAY JY NEGRIER M COMBARET V 1992Cancer Res1992,52,2:1
6Long-term follow- up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe 显示文摘Negrier S Maral J Drevon M 2000Cancer J Sci Am2000,6,:1
7Sequential sorafenib and sunitinib for renal cell carcinoma显示文摘Sablin M P Negrier S Ravaud A 2009J Urol2009,182,1:1
8Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe显示文摘Negrier S Maral J Drevon M 2000Cancer J Sci Am2000,6,1:1
9Serum level of interleukin-6 as a prognosis factor in metastatic renal cell carcinoma显示文摘Blay J Y Negrier M Combarct V 1992Cancer Research1992,52,12:1
10Serum Levels of interleukin-6 as a prognosis factor in matastatic renal cell carcimoma显示文摘Blay JY Negrier M Combaret V 1992Cancer Res1992,52,2:1
11Sorafenib in advanced clear-cell renal-cell carcinoma显示文摘 Eisen T Stadler WM Szczylik C Oudard S Siebels M Negrier S Chevreau C Solska E Desai AA Rolland F Demkow T Hutson TE Gore M Freeman S Schwartz B Shan M Simantov R Bukowski RM Target Study Group 2007N Engl J Med2007,356,2:1
12Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial显示文摘Robert J Motzer Bernard Escudier Piotr Tomczak Thomas E Hutson M Dror Michaelson Sylvie Negrier Stephane Oudard Martin E Gore Jamal Tarazi Subramanian Hariharan Connie Chen Brad Rosbrook Sinil Kim Brian I Rini 2013Lancet Oncology2013,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费